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Abstract

Purpose
A new diagnosis of cancer will often cause an individual to feel overwhelmed, confused
and anxious (Kessels, 2003). Many patients often experience anxiety not only related to their
cancer diagnosis but also in regards to the plausible side effects of chemotherapy (Greene, Nail,
Fieler, Dudgeon, & Jones, 1994; Williams & Schreier, 2004). The purpose of this paper is to
evaluate the association between timing of education provided to newly diagnosed patients
undergoing chemotherapy for breast cancer and number of self-manageable triage calls to the
oncologist’s office
Methods
A retrospective study design was conducted on newly diagnosed breast cancer patients
from January 1, 2016 to December 31, 2016, undergoing chemotherapy in two NCI clinics.
The inclusion criteria consisted of medical records of males and females 18 years of age and
older with a new breast cancer diagnosis, completed at least two cycles of chemotherapy, English
as the primary language spoken and written, received standard of care only (no research trial)
and received education at the initial visit or within 2 weeks of the initial physician visit. A total
of 59 records were included in the study. Thirty patients were educated on the same day (Group
A) as their initial visits with the oncologist and 29 were educated within two weeks of their
initial visit (Group B).
Results
The first objective determined if the nature of the call for Group A involved symptom
management in the form of diarrhea < 24 hours, fever < 100.4 degrees Fahrenheit or
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nausea/vomiting < 24 hours, within the first two cycles of chemotherapy. The number of triage
calls that met the criteria was 30% for Group A and 21% for Group B.
The second objective compared the number of triage phone calls for Group A and Group
B to determine if there was a variation contributable to timing of education. A chi-square test
showed that there was no statistical significance between the two groups.
Conclusion
In conclusion, the results of this study did not show a substantial difference in the
outcome based on when the patients and caregivers were educated. Additional research needs to
be done to focus on other types of cancer and other factors that could influence patient selfmanagement of common side effects of chemotherapy
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Introduction
At the end of 2016, there were approximately 1,685,210 new cases of cancer diagnosed
and 595,690 cancer related deaths in the United States (American Cancer Society [ACS], 2016).
Cancer is now the second leading cause of death in the United States and accounts for one out of
every four deaths; it is second to heart disease (ACS, 2016).
Breast cancer has the highest expected occurrence rate for females at a frequency of
246,660 new cases per year according to the ACS published 2016 annual report; lung and
bronchus cancers are the second highest for both men and women with an estimated incidence of
224,390 new cases annually (ACS, 2016). Brain and other nervous system cancers have one of
the lowest expected occurrence rates at 23,770 new cases annually (ACS, 2016). New cases of
male only breast cancer in 2017 thus far are 2,470 with 460 deaths. Male breast cancer is rare and
the mean age of diagnosis is 60 to 70 years of age (National Cancer Institute, 2017).
A new diagnosis of cancer can cause an individual to feel overwhelmed or anxious and
often be described as the worst fear a person possesses (Anderson, 2017; Kessels, 2003). Many
patients often experience anxiety not only related to their cancer diagnosis but also in regards to
the plausible effects of chemotherapy (ACS, 2016; Greene, Nail, Fieler, Dudgeon, & Jones,
1994; Williams & Schreier, 2004). The exhibited anxiety can cause a reduction in the amount of
information retained by the patient and caregivers who may also be involved in the education
process. Kessels (2003) stated patients should not be educated during a time of high anxiety
because of the probability they will be unable to realistically listen and sustain what is being
discussed. Thought needs to be given as to when the appropriate time would be to deliver
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information and education regarding cancer treatment. The purpose of this paper is to evaluate
the timing of education provided to newly diagnosed patients undergoing chemotherapy.

Literature Review
There is little known regarding the optimal time for chemotherapy education. A literature
review was conducted using the search engines EBSCOhost, PubMed, CINAHL and Google
Scholar. Key terms and phrases included in the search contained timing of education in new
illnesses due to limited results specific to chemotherapy. Many studies have demonstrated the
importance of educating patients prior to the first cycle of treatment but there has been no
consensus as to the best way or what “prior to the first treatment” specifically means (FeeSchroeder, Howell, Kokal,, Bjornsen, Christensen, Hathaway, & Vickers, 2013; Garcia, 2014;
Valenti, 2014). With cancer and chemotherapy already being a life changing event, it is the
responsibility of care providers to determine when education should be implemented. Without
evidence to rely on, a provider is left to speculate when the best time is to educate a patient. This
decision should be made according to what affords the best outcome for the patient.
Rönnlund, Sundström, Sörman, and Nilsson (2013), conducted a cohort study with 721
participants who were categorized as high stressed or low stressed. The intent was to determine if
high stress conditions impaired an individual’s memory and ability to retain information. Levels
of perceived stress were measured by a researcher developed questionnaire and validated with
the Perceived Stress Questionnaire. Participants with perceived higher stress rated their memory
as worse over time than participants with perceived lower stress.
In 2017, Morgan, Cooper, Paul, Hammer, Conley, Levine, Miaskowski and Dunn,
performed a longitudinal study that classified three groups of cancer patients based on their
4

personality traits. They were labeled as the “distressed”, “resilient” and “normative” groups. The
distressed group had higher levels of depression and anxiety and lower scores in the personality
domains of agreeableness and extroversion. The resilient group had lower levels of depression
and anxiety and higher in agreeableness and extroversion. The normative group scored higher in
depression and anxiety than the resilient group but their scores on the personality domains were
between the distressed and resilient groups. The distressed group showed there was a negative
effect on health outcomes due to depressive and anxiety exhibiting behavior. This group
demonstrated a less efficient way to deal with adverse effects from chemotherapy than the
groups who were scored as resilient or normative.
A further concern among providers is the delivery of education. Oncology nurses,
educators, physicians and patient advocates from Mayo Clinic established a task force to develop
an evidence based chemotherapy curriculum (Fee-Schroeder et al., 2013). The curriculum
consisted of a nurse led education session that began with an 11 minute video on managing
chemotherapy side effects followed by a question and answer session. There were 81
participants, 66 patients with cancer and 15 caregivers. This intervention demonstrated positive
outcomes and found that many patients were able to appropriately self-manage side effects at
home.
Valenti (2014) stated it was imperative for nurses and patients to develop a positive
rapport. The importance of the relationship was to foster patient and caregiver comfort allowing
the patient to ask questions and express themselves when they did not understand something.
Garcia (2014) found that when education was provided in a quiet environment and prior to the
first treatment, greater success was achieved. In addition, nurses who participated in a study to
evaluate self-care agency of patients receiving outpatient chemotherapy believed that
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understanding chemotherapy, the side effects that could occur and how to properly manage these
adverse events, had shown a positive impact on patient success by not having to delay treatment
(Kawasaki, Uchinuno, Arao, Kobayashi, & Otsuka, 2011). The ability to avoid delays in
treatment has been found to promote better overall outcomes for the patient (ChavezMacGregor, Clarke, Lichtensztajin & Giordano, 2016).

Significance
An initial office visit with the oncologist can be an overwhelming experience because
patients frequently meet with multiple disciplines such as physical therapy, speech therapy and
nurse navigator. While the main focus is the total care of the patient, each discipline has a
specific agenda. A future appointment would give the patient time to process the information
obtained from the physician visit and compile a list of questions concerning future aspects of
their journey. Chemotherapy education is vital to the success of a patient completing their
treatment plan. If adverse events begin to occur and early intervention can halt the progression,
delay in treatment can be avoided. One way this could transpire is providing necessary
information to the patient and caregivers at an appropriate time.
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Theoretical Framework
A multitude of elements are significant in terms of totality but independence and selfsufficiency are two focal points essential to the fundamentality of life. Common knowledge
recognizes that self-sufficiency is intrinsic and is an underlying element to the success of health.
With this awareness, the self-care deficit nursing theory (SCDNT) cultivates the core of nursing
(Orem, 2001; O’Shaughnessy, 2014).
Orem’s (2001) theory of self-care deficit focuses on a patient’s ability to care for
themselves and take active responsibility for their health. Understanding chemotherapy, the
effects that could occur and how to properly manage these adverse events, has shown a positive
impact on a patient’s success (Kawasaki, Uchinuno, Arao, Kobayashi, & Otsuka, 2011). An
empowered patient is more likely to be confident and trust themselves when making decisions.
Being proactive can prevent adverse reactions from turning into serious complications requiring
hospitalization.
Patients should feel empowered and truly integrated in their plan of care. Without input
from the involved patient and family, expectations may be set higher than accomplishable or too
low for the patient’s capability; both scenarios lead to failure of the provider’s role. True healing
is maximizing a patient’s ability to perform ADL’s and assist when and where needed. This is
not to be confused with providing guidance and education to patients and families with each
interaction. Education will assist patients and their families to make appropriate, practical
decisions permitting them the opportunity to participate in their plan of care.
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Objective
The purpose of this study was to evaluate the timing of education provided to newly
diagnosed patients undergoing chemotherapy at two Norton Cancer Institute (NCI) clinics that
both provided care for patients with breast cancer. In both clinics chemotherapy education was
provided by a nurse educator.

One clinic (Group A) provided chemotherapy education at the

initial visit with the oncologist and the other clinic (Group B) provided chemotherapy education
at a later scheduled visit. Specific objectives included:
1. Determining the number and type of symptom based triage phone calls received
within the first two cycles of chemotherapy for Groups A and B.
2. Comparing the number of triage phone calls for Group A and Group B to see if
there was a variation contributable to timing of education.
Emphasis of this project was directed at whether the timing of chemotherapy education
had an impact on a patient and their caregivers’ success at effectively self-managing common side
effects such as diarrhea < 24 hours, fever < 100.4 degrees Fahrenheit or nausea/vomiting < 24
hours (ACS, 2016).

8

Method
A retrospective study design was conducted to evaluate the timing of providing education
to newly diagnosed breast cancer patients undergoing chemotherapy in two NCI clinics. The
inclusion criteria consisted of medical records of males and females 18 years of age and older
with a new breast cancer diagnosis, completed at least two cycles of chemotherapy, English as
the primary language spoken and written, received standard of care only (no research trial) and
received education at the initial visit or within 2 weeks of the initial physician visit. Exclusion
criteria was males and females less than 18 years of age, patients who were pregnant,
incarcerated, had a developmental handicap, diagnosis of any cancer other than breast, English
not primary language spoken and written, new diagnosis of cancer but participated in a research
trial.
Since the information obtained for this project was collected at two NCI clinics, approval
was obtained from NCI’s Chief Nursing Officer, Norton Healthcare Office of Research
Administration (NHORA) and University of Kentucky Institutional Review Board (IRB).
Because the project was a retrospective chart review, obtaining informed consent was not
practical. Therefore, a waiver of informed consent was obtained.
A data request form with inclusion criteria was submitted to Norton Healthcare
Information Technology department. The specified observation period requested was January 1,
2016 through December 31, 2016. A report was returned consisting of 184 medical records of
patients seen during the time period. Each record was first reviewed to see if chemotherapy was
received and if so, when the patient received education. If the patient did not receive
chemotherapy, the record was excluded. The remaining records were further divided into two
groups depending on when education was initiated. The first 30 records of patients who received
education on the day they met with the oncologist were placed in Group A. The first 30 records
9

of patients who received education within 2 weeks after meeting with the oncologist were placed
in Group B. Each of the sixty medical records used for data collection were first de-identified by
using a crosswalk table and assigning a unique study number and letter to each chart. This
unique number and letter were the only information used for the remainder of the project.

Results
Objective 1.
The first objective was to determine the type of triage calls received in the clinic within
the first two cycles of chemotherapy. If the nature of the call involved symptom management in
the form of diarrhea < 24 hours, fever < 100.4 or nausea/vomiting < 24 hours, the chart was used
as part of the data collection. A total of 60 charts total were included; 30 patients were educated
the same day as oncologist visit (group A) and 30 patients were educated within two weeks of
the initial visit (group B).
Of the 30 patients’ educated on the same day as their oncologist visit (Group A), 21
patients, or 70%, either did not contact the office at all within the first two chemotherapy cycles
or did not meet the symptom based criteria. Nine patients, or 30%, did contact the office within
the first two cycles.
Of the 30 patients’ not educated same day as their oncologist visit (Group B), 24 patients,
or 79%, either did not contact the office at all within the first two chemotherapy cycles or did not
meet the symptom based criteria. Six patients, or 21%, did contact the office within the first two
cycles.
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Objective 2.
The second objective was to compare the number of triage phone calls for Group A and
Group B to see if there was a variation contributable to timing of education. To test the
association between timing of education and number of self-manageable symptom based triage
calls received within the two specified groups, data were analyzed by a chi-square test using the
SPSS program, version 23, by IBM. Results showed no statistically significant difference
between timing of education and number of triage calls (x2 = 0.674, df = 1, p = .412).
Of the nine patients in Group A that contacted the office within the first two cycles of
chemotherapy, three called once, five called twice and one called three times. Of the six patients
in Group B who contacted the office within the first two cycles of chemotherapy, four called
once, one called twice and one called three times. Regardless of the group, all calls were selfmanageable symptom based triage calls.

Discussion
A total of 184 charts from two NCI clinics were reviewed resulting in 60 patients meeting
criteria, each with the diagnosis of breast cancer. Thirty of the patients received chemotherapy
education on the same day at their initial oncologist visit, while 30 patients received
chemotherapy education within two weeks of their initial oncologist visit.
The results demonstrated that out of the 30 patients educated on the same day as their
oncologist appointment, 70% or 21 patients, either did not call the triage line or had a symptom
or concern other than diarrhea < 24 hours, fever < 100.4 degrees Fahrenheit or nausea/vomiting
< 24 hours. Of the 30 patients who received education within 2 weeks post oncologist visit, 79%
(n = 24), either did not call the triage line or had a symptom or concern other than diarrhea < 24
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hours, fever < 100.4 degrees Fahrenheit or nausea/vomiting < 24 hours. These results were not
statistically significant and did not establish an obvious contrast as originally thought. One
explanation for the findings may be that both groups received adequate education on how to
properly self-manage expected side effects. In addition, patients may have looked up information
on symptom management on the internet or had a family member or friend who provided
guidance.
Due to the current void in research, it is difficult to establish if there is a right or wrong
time to provide chemotherapy patient education. Kessel (2003) determined that patients are less
receptive to retaining education if anxiety levels are elevated. Valenti (2014) and Garcia (2014)
each demonstrated certain elements critical to a patient receiving maximum benefit from
education. Two of the most common elements were establishing a reliable, trustworthy rapport
with the nurse educator and receiving education prior to the first treatment. While a good rapport
can be established and maintained at the initial office visit, specification as to what prior to the
first treatment means is subjective.
Orem’s SCDNT encourages a provider to practice in a fashion that provides assistance to
patients, in any stage of illness or affliction, to return back to their baseline as appropriate. The
means to return a patient to their previous functional abilities is an oscillating process requiring
reinforcement, flexibility, fortitude and encouragement. Support and accessibility must be
maintained throughout the duration of the provider/patient relationship.
Patients need to feel empowered and truly integrated in their plan of care. Without input
from the involved patient and family, expectations may be set higher than accomplishable or too
low for the patient’s capability. True healing is maximizing a patient’s ability to perform ADL’s
and assist when and where needed. This is not to be confused with providing guidance and
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education to patients and families with each interaction. Education will assist patients and their
families to make appropriate, practicable decisions permitting them opportunity to partake in
their plan of care.
Limitations
There were several limitations in this study. Only individuals diagnosed with a specific
type of solid tumor (breast cancer) were included in the data collection. The predominance of
included individuals were female because breast cancer only accounts for <1% of all male
cancers (National Cancer Institute, 2017).
Another limitation to be taken into consideration is the small sample size. When
conducting research, the larger the sample size the more reliable the results. The small sample
size can be attributed to the observation period of one year as well as only collecting from two
clinics. Inclusion of other cancer diagnoses and additional clinics would provide superior results.
Implications for Practice
While these results do not show considerable difference, patient education and
participation in the care plan are still vital to a successful outcome. In years prior, education had
an unspoken but understood hierarchical premise; the healthcare provider furnished instructions
and the patient was understood to be the object of care. With the changes in healthcare, it is
imperative for patients to be active contributors. Insurance companies impact and often stipulate
certain aspects of treatment generally placing more responsibility on patients and caregivers.
However, awareness must be given to the fact that just because some patients and caregivers are
capable and grasp the gist of education, many do not which results in unnecessary complications.
Each patient and caregiver is unique and must be looked at on an individual basis.
Heightened states of anxiety are evident when diagnosed with a disease such as cancer. The
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financial and mental burden placed on a newly diagnosed person may not be avoidable but how
the patient is prepared and cared for by healthcare providers can be enhanced (Yan, Lijuan,
Xingu, Mei, Huijuan & Yusheng, 2017).

Conclusion
In conclusion, the results of this study did not show a statistically significant difference in
the outcome based on when the patients and caregivers were educated. Additional studies would
need to be piloted including a range of not only solid tumor but liquid tumors as well. A
multitude of factors would have to be considered focusing on the past and current mental health
status of the individual and what type of support system they embody. While it is important to
remember that a difference was not seen regarding time appropriate education within this study,
each diagnosis, patient and social environment must be looked at on an individual basis and
acted on accordingly.
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Table 1
Cross Tabulation with Comparing Timing of Education and the Number of Self-manageable
Symptom Based Triage Call

Phoned office with
self-manageable side
effects

Educated day of
oncologist visit
(Group A)

Educated within two
weeks of oncologist
visit
(Group B)

9 (30%)

6 (20.69%)

21 (70%)

23 (79.31%)

30 (100%)

29 (100%)

Yes

No
Total

Χ2 = 0.674, df = 1, p > .05

15

References

American Cancer Society (2016). Cancer facts and figures 2016. Retrieved from
http://www.cancer.org/acs/groups/content/@research/documents/document/acspc047079. Pdf
American Cancer Society (2016). Chemotherapy side effects. Retrieved from
https://www.cancer.org/treatment/treatments-and-side-effects/treatmenttypes/chemotherapy/chemotherapy-side-effects.html
Anderson, B. (2017). An insight into the patient’s response to a diagnosis of urological cancer.
British Journal of Nursing, 26, S4-S12
Chavez-MacGregor, M., Clarke, C., Lichtensztajin, D & Giordano, S. (2016). Delayed
initiation of adjuvant chemotherapy among patients with breast cancer. Journal of the
American Medical Association, 2(3), 322-329. doi:10.1001/jamaoncol.2015.3856
Eggenberger, S., Krumwiede, N., Meiers, S., Bliesmer, M., & Earle, P. (2004). Family caring
strategies in neutropenia. Clinical Journal of Oncology Nursing, 8, 617-620
Fee-Schroeder, K., Howell, L., Kokal, J., Bjornsen, S., Christensen, S., Hathaway, J. & Vickers,
K. (2013). Empowering individuals to self-manage chemotherapy side effects. Clinical
Journal of Nursing, 17, 369-371
Garcia, S. (2014). The effects of education on anxiety levels in patients receiving
chemotherapy for the first time: An integrative review. Clinical Journal of Oncology
Nursing, 18, 516- 521

16

Kawasaki, Y., Uchinuno, A., Arao, H., Kobayashi, T., & Otsuka, N. (2011). Evaluating the
self- care agency of patients receiving outpatient chemotherapy. Clinical Journal of
Oncology Nursing, 15, 668-673
Kessels, R.P. (2003). Patients’ memory for medical information. Journal of the Royal Society
of Medicine, 96, 219-222
Loftus, E., Banaji, M., Schooler, J. & Foster, R. (1987). Who remember what? : Gender
differences in memory. Michigan Quarterly Review, 26, 64-85
Morgan, S., Cooper, B., Paul, S., Hammer, M., Conley, Y., Levine, J., Miaskowski, C., & Dunn,
L. (2017). Association of personality profiles with depressive, anxiety, and cancer-related
symptoms in patients undergoing chemotherapy. Personality and Individual Differences,
117, 130-138. doi.org/10.1016/j.paid.2017.05.039
National Cancer Institute. (2017). Male breast cancer treatment. National Institutes of Health,
2017. Last accessed October 2017
Orem D. E. (2001). Nursing concepts of practice (6th ed.). St. Louis, MO: Mosby
O’Shaughnessy, M. (2014, September-October). Application of Dorothea Orem’s theory of selfcare to the elderly patient on peritoneal dialysis. Nephrology Nursing Journal, 41, 495497

17

Rönnlund, M., Sundström, A., Sörman, D. and Nilsson, L. (2013). Effects of perceived longterm stress on subjective and objective aspects of memory and cognitive functioning in
a middle-aged population-based sample. The Journal of Genetic Psychology, 174, 2541. Retrieved from
http://www.tandfonline.com.ezproxy.uky.edu/doi/abs/10.1080/00221325.2011.635725
Valenti, R. B. (2014). Chemotherapy education for patients with cancer: A literature review.
Clinical Journal of Oncology Nursing, 18, 637-640.
Williams, P., Williams, K., LaFaver-Roling, S., Johnson, R., & Williams, A. (2011). An
intervention to manage patient-reported symptoms during cancer treatment. Clinical
Journal of Oncology Nursing, 15, 253-258
Williams, S., & Schreier, A. (2004). The effect of education in managing side effects in women
receiving chemotherapy for treatment of breast cancer. Oncology Nursing Forum, 31,
E16-E23
Yan, Y., Lijuan, H.., Xingu, C., Mei, G., Huijuan, Z., & Yusheng, Y. (2017). The impact of the
predictive nursing education process on degree of comfort and quality of life for patients
in the oncology department. Iranian Journal of Public Health, 46, 1231-1236

18

